Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...
Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...
Sept. 2, 2025 — Stereotaxis has announced the successful completion of the world’s first procedures using MAGiC Sweep, a ...
July 1, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, has ...
April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...
June 19, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
June 11, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, today ...
May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...
May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
March 12, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...